REATA PHARMACEUTICALS INC (30)

Browse by Contract Category

Contracts

Notice of Grant of Restricted Stock Units for employees, dated as of December 2, 2020 (Filed With SEC on May 6, 2021)
Indemnification Agreement by and between the Company and Shamim Ruff, dated as of April 15, 2021 (Filed With SEC on April 15, 2021)
Fifth Amended and Restated Non-Employee Director Compensation Policy, dated as of December 2, 2020 (Filed With SEC on March 1, 2021)
First Amendment to Lease Agreement, dated as of May 27, 2020 (Filed With SEC on August 10, 2020)
Description of Registrants Securities (Filed With SEC on February 19, 2020)
Amended and Restated License Agreement, dated as of October 9, 2019 (Filed With SEC on October 10, 2019)
Indemnification Agreement by and between the Company and Christy J. Oliger, dated as of April 15, 2021 (Filed With SEC on April 15, 2021)
Notice of Grant of Restricted Stock Units for director/consultants, dated as of December 2, 2020 (Filed With SEC on March 1, 2021)
Underwriting Agreement, dated December 1, 2020, by and among Reata Pharmaceuticals, Inc. and the Representatives (Filed With SEC on December 3, 2020)
Fourth Amended and Restated Non-Employee Director Compensation Policy, dated as of June 10, 2020 (Filed With SEC on August 10, 2020)
Development and Commercialization Funding Agreement between the Company and BXLS V River L.P, dated as of June 10, 2020 (Filed With SEC on August 10, 2020)
Common Stock Purchase Agreement between the Company and BXLS V River L.P, dated as of June 10, 2020 (Filed With SEC on August 10, 2020)
Indemnification Agreement by and between the Company and Martin W. Edwards, dated as of August 3, 2020 (Filed With SEC on July 31, 2020)
Denbury Lease Expansion Agreement, dated December 12, 2019 (Filed With SEC on February 19, 2020)
Third Amended and Restated Non-Employee Director and Compensation Policy dated as of December 11, 2019 (Filed With SEC on February 19, 2020)
Gateway Lease Expansion Agreement, dated December 12, 2019 (Filed With SEC on February 19, 2020)
Notice of Grant of Restricted Stock Units for employees (Filed With SEC on February 19, 2020)
Underwriting Agreement, dated November 13, 2019, by and among Reata Pharmaceuticals, Inc. and the Representatives (Filed With SEC on November 14, 2019)
Notice of Grant of Restricted Stock Units for employees (Filed With SEC on November 12, 2019)
Restricted Stock Unit Agreement (Filed With SEC on November 12, 2019)
Employment Agreement by and between the Company and Manmeet S. Soni dated August 28, 2019 (Filed With SEC on November 12, 2019)
Indemnification Agreement by and between the Company and Manmeet S. Soni dated August 28, 2019 (Filed With SEC on November 12, 2019)
First Amendment to Amended and Restated Loan and Security Agreement, dated as of October 9, 2019 (Filed With SEC on October 10, 2019)
Sixth Supplement to Exclusive License and Supply Agreement, dated August 22, 2019, between Reata Pharmaceuticals, Inc. and Kyowa Kirin Co., Ltd (Filed With SEC on August 22, 2019)
Fifth Supplement to Exclusive License and Supply Agreement, dated August 22, 2019, between Reata Pharmaceuticals, Inc. and Kyowa Kirin Co., Ltd (Filed With SEC on August 22, 2019)
Notice of stock option grant forms for employees and director/consultant (Filed With SEC on May 9, 2019)
Stock Option Agreement (Filed With SEC on May 9, 2019)
Reata Pharmaceuticals, Inc. Second Amended and Restated Long Term Incentive Plan (Filed With SEC on May 9, 2019)
Notice of Stock Option Grant forms for employees and director/consultants (Filed With SEC on February 28, 2019)
Second Amended and Restated Non-Employee Director Compensation Policy dated as of December 11, 2018 (Filed With SEC on February 28, 2019)